Ardsley Advisory Partners LP Bristol Myers Squibb CO Call Options Transaction History

Ardsley Advisory Partners LP

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $10.7 Million - $12.7 Million	-250,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $11.2 Million - $12.3 Million	250,000 New	250,000 $11.3 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.